Pfizer Testing Lyme Disease Vaccine Candidate in Phase 3 Trial
VLA15 is a 6-valent protein subunit vaccine that targets the outer surface protein A of Borrelia burgdorferi.
VLA15 is a 6-valent protein subunit vaccine that targets the outer surface protein A of Borrelia burgdorferi.
Persistent somatic symptoms could be attributed to COVID-19 in an estimated 12.7 percent of patients at 90 to 150 days after COVID-19
Despite the test results, the president ‘has experienced no reemergence of symptoms and continues to feel quite well’
The extended shelf-life of Paxlovid is authorized for 4 lots that were manufactured with a 9-month expiry prior to the issuance of Emergency Use Authorization.
An individual is considered fully vaccinated about 2 weeks after the second dose of Jynneos and 4 weeks after receiving ACAM2000.
95 percent of 528 cases presented with rash; 73 and 41 percent had anogenital and mucosal lesions, respectively
Investigators now working to determine specifically how the infection happened and whether others were exposed
Unclear whether human adenovirus is the causative agent for acute hepatitis in these children
Observational study findings highlight a “persistent and marked” association between hypertension and risk for severe COVID-19, even among fully vaccinated patients, according to investigators.
The Novavax COVID-19 Vaccine, Adjuvanted is administered intramuscularly as a 2-dose primary series (0.5mL each), separated by 3 weeks.